DRUG Working Capital Ratio
Bright Minds Biosciences Inc · Working Capital Ratio
DRUG Working Capital Ratio
Latest reported97.10%period ending
DRUG FY Working Capital Ratio (26.40% → 97.10%)
Annual working capital ratio
High-resolution chart · PNG
DRUG working capital ratio history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 97.1011% | |
| 89.4122% | |
| 94.9518% | |
| 86.6687% | |
| 96.8036% | |
| 82.6267% | |
| 26.3967% |